Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
UCB S.A. - Pharma Sector
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Males/Females from 18 to 65 years of age (minimum body weight of 40 kg)
Subjects with a confirmed diagnosis of epilepsy suffering from partial onset seizures whether or not secondarily generalized
Subjects who have been treated for epilepsy for \>=6 months and are currently uncontrolled while being treated with 1-3 concomitant Antiepileptic Drug (AEDs)
You may not be if
Seizures occurring in clusters.
Status epilepticus within 6 months of Visit 1
History of non-epileptic seizures
Subjects on vigabatrin
Subjects on felbamate, unless treatment has been continuous for \>2 years
Ongoing psychiatric disease other than mild controlled disorders.
Subjects with clinically significant organ dysfunction
Known allergic reaction or intolerance to pyrrolidine derivatives and/or excipients
Pregnant or lactating women
Subjects currently taking levetiracetam (LEV)
Use of benzodiazepines (for any indication) taken at a higher frequency than an average of once a week, unless counted as one of the concomitant Antiepileptic Drug (AEDs)
